Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer, focused on exploiting specific targets on tumor cells.

Pan Cancer T

Google Maps

CrUX Dataset

CrUX Top 50m

Chief Executive Officer

Rachel Abbott

Nina Satih

European Union (EU) Therapeutics Companies

Europe Life Science Companies

European Union (EU) Startups Founded in 2020

The Netherlands Startups

Pan-Cancer T is a biotechnology spin-out from Erasmus MC, Rotterdam, the Netherlands dedicated to discovering and developing T cell receptor (TCR) T cell therapies. The company exploits 20 years of pioneering research in the field of adoptive T-cell therapies. This foundation serves as a springboard towards breakthrough therapies for solid tumors.

Seed Round - Pan Cancer

Rotterdam

Zuid-Holland

The Netherlands

Europe

Pan Cancer

Pan Cancer T–Thuja Capital: investment, 202407 seed financing round 2nd expansion totalling €4.25m incl existing investor Thuja Capital

Pan Cancer T–Scius Communications: public relations, 202407 supply service existent by Scius Communications

Pan Cancer T secures €4.25 Million in Seed Extension Round to advance next-generation T cell therapies

Pan Cancer T taking T-cell therapies into solid tumors

Pan Cancer T–Abbott R: management, 202305– CEO joined as CSO 1/23 before Enara Bio + Adaptimmune

India

Asia

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 26, 2024 2:21 PM	4303bccf
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 26, 2024 2:21 PM	08030e99
crunchbase trigger	general	Oct 28, 2024 1:51 PM	869d613d
crunchbase profile	general	Oct 29, 2024 8:56 AM	75e63d1f
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	2c00e2b5
peers	general	Sep 26, 2024 2:21 PM	a01ca75c
news basic	general	Sep 26, 2024 2:21 PM	fedc5adf
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PANCANCER-T

Pan Cancer T